Home Page / Exhibitors / Deep6 AI

Deep6 AI

Pasadena, CA 91106-4530
Booth(s):  9900-B

About

Using artificial intelligence on medical records, Deep 6 AI finds more, better-matching patients for clinical trials in minutes, not months, getting life-saving cures to patients more quickly. Deep 6 AI also helps sponsors and CROs with better trial feasibility design, site selection, real-time analysis of study results, and improved trial response rates. Deep 6 AI is a Techstars, StartX and Healthbox alum and current participant in the Texas Medical Center Accelerator. For more information, visit https://deep6.ai

Press Releases

PASADENA, Calif. (February 6, 2018) – Deep 6 AI is one of 23 digital health startups participating in the Texas Medical Center Accelerator (TMCx). The Texas Medical Center is the world’s largest medical center with 58 member institutions and a central research institute that provides a campus-wide R&D network, a central IRB for conducting multi-site trials, and 10 million annual patient encounters. The TMCx program, led by the TMC Innovation Institute, provides the tools and action plans necessary to move products and companies forward, regardless of stage of development, and lowers the barriers of access to hospital stakeholders and key opinion leaders across TMC. Participating startups, which were selected from more than 200 applications across 13 countries, get access to thought leaders and experts in every facet of running a health-related business – clinical trials, FDA regulations, HIPAA/HITECH compliance, hospital procurement, commercial pilots, intellectual property, licensing, fundraising, marketing, and more – without membership fees or equity sharing.Joining Deep 6 AI in this sixth cohort are the following digital health companies: fellow Cedars-Sinai Accelerator powered by Techstars alum Well HealthAbaka HealthAgathosb.wellDermaSensorEtyonEvidence CareGain LifeKlikkitLuminareNarrativeDx, ORIntel, Particle HealthPatients We ShareRevealixScalaMedSenceTechSoftcare StudiosStrados LabsSunrise HealthTrayt, and Trusted Health.

The four-month program will culminate in TMCx Demo Day on June 7, 2018.

Read more in MedCity News and TMC Xchange.

ABOUT DEEP 6 AI

Using artificial intelligence on medical records, Deep 6 AI finds more, better-matching patients for clinical trials in minutes, not months, getting life-saving cures to patients more quickly. Deep 6 AI also helps sponsors and CROs with better trial feasibility design, site selection, real-time analysis of study results, and improved trial response rates. Deep 6 AI is a Techstars, StartX and Healthbox alum and is currently in use by leading hospitals, such as Cedars-Sinai Medical Center, research institutes and CROs. The company was founded in 2015 and is based in Pasadena, CA. Learn more at https://deep6.ai

###

Contact:

Linda Souza, Deep 6 AI
pr@deep6.ai
1.626.585.8586

PASADENA, Calif. (February 13, 2018) – HIMSS has named Wout Brusselaers, chief executive officer of Deep 6 AI , an artificial intelligence (AI) company focused on accelerating patient recruitment for clinical trials, as a speaker for the 2018 HIMSS Conference & Exhibition (HIMSS18). Brusselaers will co-present the “Finding the ROI of AI” educational session with Bobbie J. Rimel, MD, gynecologic oncologist and associate director for gynecological clinical trials at Cedars-Sinai Medical Center, on March 8, 2018 at 2:30 pm PT. HIMSS18 brings together 45,000+ health information and technology professionals, clinicians, executives and vendors from around the world. Exceptional education, excellent speakers, cutting-edge health information and technology products and powerful networking are hallmarks of this industry-leading conference.

“Finding the ROI of AI” will explore the role of artificial intelligence in enabling health systems to perform more clinical trials, boost revenues, attract and retain talent and provide patients with access to cutting-edge treatments. Brusselaers and Dr. Rimel will illustrate the return on investment (ROI) of AI through case study examples in which researchers benchmarked AI against conventional subject identification methods. Beyond patient matching, the session will examine the entire trial design and recruitment cycle to find where AI can meaningfully support stakeholders and how accelerated patient recruitment for clinical trials impacts a health system’s revenue stream.

The HIMSS Annual Conference Education Committee (ACEC) selected the more than 350 educational sessions on the conference program. Proposals under review by the ACEC have gone through a peer-review selection process for enhanced efficiency and quality in selection of the educational offerings at the conference. This committee, composed of 16 appointed HIMSS volunteers from across all member constituencies, reviews and selects all presentations with those representing an organization or non-commercial interest given preference, a guideline followed to achieve continuing medical education or CME requirements.

“HIMSS18 offers relevant programming and actionable information that our attendees can use in their own work settings. Our speakers will share their insights on a variety of topics during the more than 350 education sessions scheduled before and during the conference, as well as on the exhibition floor,” said JoAnn W. Klinedinst, MEd, CPHIMS, PMP, DES, FHIMSS, vice president, professional development, for HIMSS. “I congratulate the presenters who will be part of our globally extensive and diverse programming schedule for HIMSS18.”

You can also find Deep 6 AI in the HIMSS18 Innovation Live area in the Cedars-Sinai Accelerator powered by Techstars booth. HIMSS18 takes place in Las Vegas, Nevada from March 5–9, 2018 at the Venetian – Palazzo – Sands Expo Center. Follow the conversation at #HIMSS18

ABOUT DEEP 6 AI

Using artificial intelligence on medical records, Deep 6 AI finds more, better-matching patients for clinical trials in minutes, not months, getting life-saving cures to patients more quickly. Deep 6 AI also helps sponsors and CROs with better trial feasibility design, site selection, real-time analysis of study results, and improved trial response rates. Deep 6 AI is a Techstars, StartX and Healthbox alum and is currently in use by leading hospitals, such as Cedars-Sinai Medical Center, research institutes and CROs. The company was founded in 2015 and is based in Pasadena, CA. Learn more at https://deep6.ai

###

Contact:

Linda Souza, Deep 6 AI
pr@deep6.ai
1.626.585.8586

Product/Service Categories

WHERE THE WORLD
CONNECTS FOR HEALTH